⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001840408

Dolski Robert

Reports to the SEC for 2 companies · LONDON

Transactions

5

Companies

2

Filings

3

CIK

0001840408

Forms 4 and 5

Insider transactions

5 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-05-31	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−101K sh	—	—	0
2022-05-31	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−27.3K sh	—	—	0
2022-05-31	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−150K sh	—	—	0
2022-01-27	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+101K sh	—	—	101,180
2021-08-04	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+27.3K sh	—	—	27,300

Recent filings

3

Accepted (ET)
May 314
Dolski Robert0000899243-22-020083
SEC(opens sec.gov)
Jan 314
Dolski Robert0000899243-22-003633
SEC(opens sec.gov)
Aug 64
Dolski Robert0000899243-21-031912
SEC(opens sec.gov)

Companies

2

Address

C/O AUTOLUS THERAPEUTICS PLC THE MEDIAWORKS, 191 WOOD LN, WHITE CITY

LONDON, W12 7FP